Giving Routine Vaccinations a Boost
During World Immunization Week, Dr. Michael Greenberg, Medical Head, Sanofi Pasteur North America, discusses the importance of routine vaccination programs—and seizing the opportunity to catch up as we return to in-person settings.
Adapting to Stay Ahead of Preventable Infectious Threats
Our society always adapts, and this includes new ways to help protect ourselves from the spread of infectious diseases with vaccines. Elaine O’Hara, Chief Commercial Officer NA at Sanofi Pasteur, reflects on the importance of vaccines and shares the new resources Sanofi has developed for health care professionals, including our Adaptive Vaccination Solutions (AVS).
Our Response to COVID-19
At Sanofi, our purpose is to discover breakthrough medicines and vaccines to improve the lives of millions of people around the world. This drive to transform the practice of medicine for infectious diseases has taken on increased urgency for everyone in the Sanofi family since the emergence of COVID-19 across the world. Sanofi is rapidly responding to the evolving challenge of COVID-19 infection.
About Our Vaccines
We believe in a world where no one suffers or dies from a vaccine preventable disease. We are proud our vaccines can help protect us and our loved ones from a wide range of severe infectious diseases, at every stage of life.
For over 100 years, Sanofi Pasteur has been committed to extending the life-saving power of vaccination as broadly as possible. Our history is grounded in life science pioneers who discovered how infectious diseases and vaccines work. They unlocked the public health potential of vaccination for infectious diseases and developed efficient mass production methods to ensure the broadest access to vaccines. We currently supply one billion vaccine doses to people around the world each year, and work hand-in-hand with our public health partners so our vaccines can help protect as many as half a billion lives annually.
We are often unaware of the impact that infectious diseases can have on ourselves and our loved ones. They can put us at risk of serious illness, which can lead to death. Ongoing vaccination is a crucial cornerstone in keeping our communities healthy, especially when you consider that vaccines are often the best, if not, the only way to protect us from many serious infectious diseases at every stage of life. While vaccination saves up to 3 million lives every year, an additional 1.5 million deaths could be avoided with improved vaccination coverage.
Improving the world’s health entails developing new solutions to infectious diseases that affect people around the globe. Our R&D teams closely follow the latest technological advances in an effort to develop vaccines against new infectious disease targets (diseases for which there is still no means of prevention) and improve existing vaccines to advance access. We are seeking to develop effective vaccines to extend the benefits of vaccination to a number of infectious diseases, such as COVID-19 and respiratory syncytial virus infections.